Beranda › Kanker Payudara › Maryland › Germantown
Uji klinis Kanker Payudara di Germantown, MD
10 studi untuk Kanker Payudara mencari peserta di lokasi sekitar Germantown (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- MedStar Montgomery Medical Center, Olney · 11 mi jauhnya
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Menerima pesertaFase 3
- James M Stockman Cancer Institute, Frederick · 18 mi jauhnya
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Menerima pesertaFase 3
- Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg · 4 mi jauhnya
- MedStar Montgomery Medical Center, Olney · 11 mi jauhnya
- FMH James M Stockman Cancer Institute, Frederick · 18 mi jauhnya
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Menerima pesertaFase 3
- Inova Loudoun Hospital, Leesburg · 16 mi jauhnya
E-Mindfulness Approaches for Living After Breast Cancer
Menerima pesertaFase 3
- Kaiser Permanente-Gaithersburg Medical Center, Gaithersburg · 4 mi jauhnya
- MedStar Montgomery Medical Center, Olney · 11 mi jauhnya
- Inova Loudoun Hospital, Leesburg · 16 mi jauhnya
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Menerima pesertaFase 1/2
- USOR Maryland Oncology Hematology, Rockville · 9 mi jauhnya
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Menerima pesertaFase 2
- Maryland Oncology Hematology- Columbia, Rockville · 9 mi jauhnya
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Menerima pesertaFase 3
- Maryland Oncology Hematology P.A., Germantown
- Maryland Oncology Hematology P.A., Rockville · 9 mi jauhnya
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Menerima pesertaStudi observasional
- James M Stockman Cancer Institute, Frederick · 18 mi jauhnya
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Menerima pesertaStudi observasional
- Maryland Oncology Hematology - Aquilino Cancer Center, Rockville · 9 mi jauhnya
- Frederick Oncology Hematology Associates, Frederick · 18 mi jauhnya
Uji klinis Kanker Payudara di kota lain
- New York City, NY136 studi
- Houston, TX126 studi
- Boston, MA112 studi
- Nashville, TN81 studi
- Los Angeles, CA73 studi
- Edison, NJ68 studi
- St. Louis, MO64 studi
- Queens, NY64 studi
- Durham, NC64 studi
- Chicago, IL59 studi
- Philadelphia, PA56 studi
- Dallas, TX55 studi
Studi lain di Germantown
- Kanker Paru Non-Sel Kecil17 studi
- Skizofrenia11 studi
- Kanker Paru9 studi
- Kanker (semua jenis)7 studi
- Depresi7 studi
- Obesitas7 studi
- Diabetes Tipe 27 studi
- Penyakit Kardiovaskular6 studi
- Kanker Kandung Kemih6 studi
- Kelebihan Berat Badan5 studi
- Gangguan Depresi Mayor5 studi
- Tekanan Darah Tinggi4 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.